Pischon T., Lahmann P.H., Boeing H. et al. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) // Int J Cancer. 2006. Vol. 118. P. 728–38.
Petejova N., Martinek A. Renal cell carcinoma: Review of etiology, pathophysiology and risk factors // Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016. Vol. 160. No 2. Р. 183−94. DOI: 10.5507/bp.2015.050.
Sasco A.J., Secretan M.B., Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence // Lung Cancer. 2004. Vol. 45, Suppl 2. P. 3–9. DOI:10.1016/j.lungcan.2004.07.998.
Chittiboina P., Lonser R.R. von Hippel–Lindau disease // Hand Clin Neurol. 2015. Vol. 139–56. DOI:10.1016/b978-0-444-62702-5.00010-x.
Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries // CA Cancer J Clin. 2018. Vol. 68. No 6. P. 394−424. DOI: 10.3322/caac.21492.
Moch H., Cubilla A.L., Humphrey P.A. et al. The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours // Eur Urol. 2016. Vol. 70. No 1. P. 93−105.
Moch H., Humphrey P.A., Ulbright T.M., Reuter V.E. WHO (World Health Organization). Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. World Health Organization Classification of Tumours. IARC Press. Lyon, France, 2016.
Brierley J.D., Gospodarowicz M.K., Wittekind C. Eds. TNM Classification of Malignant Tumours. 8th edn. Oxford, UK: Wiley-Blackwell, 2017.
Kutikov A., Uzzo R.G. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth // J Urol. 2009. Vol. 182. No 3. P. 844–53.
Ficarra V., Novara G., Secco S. et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery // Eur Urol. 2009. Vol. 56. P. 786–93.
Novick A.C., Cosgrove D.M. Surgical approach for removal of renal cell carcinoma extending into the vena cava and the right atrium // J Urol. 1980. Vol. 123. P. 947–50.
Motzer R.J., Mazumdar M., Bacik J. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma // J Clin Oncol. 1999. Vol. 17. No 8. P. 2530−40.
Heng D.Y.., Xie W., Regan M.M. et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factortargeted agents: results from a large, multicenter study // J Clin Oncol. 2009. Vol. 27. No 34. P. 5794−9.
Chen Z., Shao Y., Yao H. et al. Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients // Oncotarget. 2017. Vol. 8. No 29. P. 48291-48302.
Abel E.J., Thompson R.H., Maqulis V. et al. Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience // Eur Urol. 2014. Vol. 66. No 3. P. 584–92.
Shen J., Chen Z., Fan M. et al. Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis // Cancer Manag Res. 2019. Vol. 11. P. 5365–74. DOI:10.2147/cmar.s199849.
Semeniuk-Wojtaś A., Lubas A., Stec R. et al. Neutrophil-to-lymphocyte ratio, platelet-tolymphocyte ratio, and c-reactive protein as new and simple prognostic factors in patients with metastatic renal cell cancer treated with tyrosine kinase inhibitors: a systemic review and meta-analysis // Clin Genitourinary Cancer. 2018. Vol. 16. No 3. P. e685–e693. DOI:10.1016/j.clgc.2018.01.010.
Hu X., Wang Y., Yang W.X. et al. Modified Glasgow prognostic score as a prognostic factor for renal cell carcinomas: a systematic review and meta-analysis // Cancer Manag Res. 2019. Vol. 11. P. 6163−73. DOI: 10.2147/CMAR.S208839. eCollection. 2019.
Kara Ö., Maurice M.J., Mouracade P. et al. Preoperative proteinuria is associated with increased rates of acute kidney injury after partial nephrectomy // Int Braz J Urol. 2019. Vol. 45. DOI: 10.1590/S1677-5538.IBJU.2018.0776.
Potretzke A.M., Knight B.A., Vetter J.M. et al. Diagnostic utility of selective upper tract urinary cytology: a systematic review and meta-analysis of the literature // Urology. 2016. Vol. 96. P. 35–43. DOI: 10.1016/j.urology.2016.04.030.
Rossi S.H., Hsu R., Blick C. et al. Meta-analysis of the prevalence of renal cancer detected by abdominal ultrasonography // Br J Surg. 2017. Vol. 104. No 6. P. 648–59. DOI: 10.1002/bjs.10523.
Vogel C.Ziegelmüller B., Ljungberg B. et al. Imaging in Suspected Renal Cell Carcinoma: Systematic Review // Clin Genitourin Cancer. 2019. Vol. 17. No 2. P. 345−55. DOI: 10.1016/j.clgc.2018.07.024.
Salameh J.P., McInnes M.D.F., McGrath T.A. et al. Diagnostic accuracy of dualenergy ct for evaluation of renal masses: systematic review and meta-analysis // AJR Am J Roentgenol. 2019. Vol. 212. No 4. P. W100−5. DOI: 10.2214/AJR.18.20527.
Sevcenco S., Spick C., Helbich T.H. et al. Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography — a systematic review and meta-analysis // Eur Radiol. 2016. Vol. 27. No 6. P. 2239–47. DOI: 10.1007/s00330-016-4631-9.
Chiarello M.A., Mali R.D., Kang S.K. Diagnostic accuracy of MRI for detection of papillary renal cell carcinoma: a systematic review and meta-analysis // AJR Am J Roentgenol. 2018. Vol. 211. No 4. P. 812−21. DOI: 10.2214/AJR.17.19462.
Nomoto N., Tani T., Konda T. et al. Primary and metastatic cardiac tumors: echocardiographic diagnosis, treatment and prognosis in a 15-years single center study // J Cardiothorac Surg. 2017. Vol. 12. No 1. P. 103.